Can we identify patients at high risk of recurrent Clostridium difficile infection?KELLY, C. P.Clinical microbiology and infection. Supplement. 2012, Vol 18, Num 6, pp 21-27, issn 1470-9465, 7 p.Article

ESCMID^* guideline for the diagnosis and management of Candida diseases 2012: patients with HIV infection or AIDSLORTHOLARY, O; PETRIKKOS, G; CUENCA-ESTRELLA, M et al.Clinical microbiology and infection. Supplement. 2012, Vol 18, Num 7, pp 68-77, issn 1470-9465, 10 p.Article

ESCMID^* guideline for the diagnosis and management of Candida diseases 2012: prevention and management of invasive infections in neonates and children caused by Candida sppHOPE, W. W; CASTAGNOLA, E; CUENCA-ESTRELLA, M et al.Clinical microbiology and infection. Supplement. 2012, Vol 18, Num 7, pp 38-52, issn 1470-9465, 15 p.Article

ESCMID^* guideline for the diagnosis and management of Candida diseases 2012: adults with haematological malignancies and after haematopoietic stem cell transplantation (HCT)ULLMANN, A. J; AKOVA, M; CORNELY, O. A et al.Clinical microbiology and infection. Supplement. 2012, Vol 18, Num 7, pp 53-67, issn 1470-9465, 15 p.Article

Evolution of genetic diversity using networks: the human gut microbiome as a case studyBAPTESTE, E; BICEP, C; LOPEZ, P et al.Clinical microbiology and infection. Supplement. 2012, Vol 18, Num 4, pp 40-43, issn 1470-9465, 4 p.Article

Laboratory-based diagnosis of pneumococcal pneumonia: state of the art and unmet needsVERNET, G; SAHA, S; SATZKE, C et al.Clinical microbiology and infection. Supplement. 2011, Vol 17, Num 3, pp 1-13, issn 1470-9465, 13 p.Article

Optimizing outcomes in patients with serious Gram-positive infectionsMESTRES, Carlos.Clinical microbiology and infection. Supplement. 2009, Vol 15, Num 6, issn 1470-9465, 34 p.Conference Proceedings

Current experience in treating invasive zygomycosis with posaconazoleCORNELY, O. A; VEHRESCHILD, J. J; RÜPING, M. J. G. T et al.Clinical microbiology and infection. Supplement. 2009, Vol 15, Num 5, pp 77-81, issn 1470-9465, 5 p.Conference Paper

Hyperbaric oxygen therapy and other adjunctive treatments for zygomycosisTRAGIANNIDIS, A; GROLL, A. H.Clinical microbiology and infection. Supplement. 2009, Vol 15, Num 5, pp 82-86, issn 1470-9465, 5 p.Conference Paper

Maximizing positive outcomes for patients with staphylococcal infectionsSTAHL, J.-P.Clinical microbiology and infection. Supplement. 2009, Vol 15, Num 6, pp 26-32, issn 1470-9465, 7 p.Conference Paper

Orbitomaxillary mucormycosis zygomycosis and the surgical approach to treatment: perspectives from a maxillofacial surgeonRAPIDIS, A. D.Clinical microbiology and infection. Supplement. 2009, Vol 15, Num 5, pp 98-102, issn 1470-9465, 5 p.Conference Paper

Infection control measures to limit the spread of Clostridium difficileVONBERG, R.-P; KUIJPER, E. J; DEBAST, S et al.Clinical microbiology and infection. Supplement. 2008, Vol 14, Num 5, pp 2-20, issn 1470-9465, 19 p.Article

ESBLs, Forever? Proceedings of the ESCMID Conference on Extended-spectrum Beta-lactamasesCORNAGLIA, G; GARAU, J; LIVERMORE, D. M et al.Clinical microbiology and infection. Supplement. 2008, Vol 14, Num 1, issn 1470-9465, 205 p.Conference Proceedings

Contribution of new diagnostic approaches to antifungal treatment plans in high-risk haematology patientsEINSELE, H; LOEFFLER, J.Clinical microbiology and infection. Supplement. 2008, Vol 14, Num 4, pp 37-45, issn 1470-9465, 9 p.Article

Antimicrobial resistance in Europe and its potential impact on empirical therapyROSSOLINI, G. M; MANTENGOLI, E.Clinical microbiology and infection. Supplement. 2008, Vol 14, Num 6, pp 2-8, issn 1470-9465, 7 p.Conference Paper

Breakpoints for intravenously used cephalosporins in Enterobacteriaceae-EUCAST and CLSI breakpointsKAHLMETER, G.Clinical microbiology and infection. Supplement. 2008, Vol 14, Num 1, pp 169-174, issn 1470-9465, 6 p.Conference Paper

Evolution of extended-spectrum β-lactamases by mutationGNIADKOWSKI, M.Clinical microbiology and infection. Supplement. 2008, Vol 14, Num 1, pp 11-32, issn 1470-9465, 22 p.Conference Paper

Future strategies for treating Staphylococcus aureus bloodstream infectionsNABER, C. K.Clinical microbiology and infection. Supplement. 2008, Vol 14, Num 2, pp 26-34, issn 1470-9465, 9 p.Conference Paper

Other antimicrobials of interest in the era of extended-spectrum β-lactamases : fosfomycin, nitrofurantoin and tigecyclineGARAU, J.Clinical microbiology and infection. Supplement. 2008, Vol 14, Num 1, pp 198-202, issn 1470-9465, 5 p.Conference Paper

Phenotypic detection of extended-spectrum β-lactamase production in Enterobacteriaceae : review and bench guideDRIEUX, L; BRASSIER, F; SOUGAKOFF, W et al.Clinical microbiology and infection. Supplement. 2008, Vol 14, Num 1, pp 90-103, issn 1470-9465, 14 p.Conference Paper

What's new and not so new on the antimicrobial horizon?FRENCH, G. L.Clinical microbiology and infection. Supplement. 2008, Vol 14, Num 6, pp 19-29, issn 1470-9465, 11 p.Conference Paper

Redesigning β-lactams to combat resistance : summary and conclusionsROSSOLINI, G. M.Clinical microbiology and infection. Supplement. 2007, Vol 13, Num 2, pp 30-33, issn 1470-9465, 4 p.Article

Clinical experience in the management of community-acquired pneumonia : lessons from the use of fluoroquinolonesCARRATALD, J; MARTIN-HERRERO, J. E; MYKIETIUK, A et al.Clinical microbiology and infection. Supplement. 2006, Vol 12, Num 3, pp 2-11, issn 1470-9465, 10 p.Article

Should patients with acute exacerbation of chronic bronchitis be treated with antibiotics? Advantages of the use of fluoroquinolonesMENSA, J; TRILLA, A.Clinical microbiology and infection. Supplement. 2006, Vol 12, Num 3, pp 42-54, issn 1470-9465, 13 p.Article

Levofloxacin in the treatment of ventilator-associated pneumoniaALVAREZ-LERMA, F; GRAU, S; ILVAREZ-BELTRDN, M et al.Clinical microbiology and infection. Supplement. 2006, Vol 12, Num 3, pp 81-92, issn 1470-9465, 12 p.Article